Jin Zhu
8PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 17, 2022
Drug Repurposing of Quisinostat to Discover Novel Plasmodium falciparum HDAC1 Inhibitors with Enhanced Triple-Stage Antimalarial Activity and Improved Safety.Manjiong Wang, Tongke Tang, Ruoxi Li
|Aug 20, 2021
Antiaging Effects of Vicatia thibetica de Boiss Root Extract on Caenorhabditis elegans and Doxorubicin-Induced Premature Aging in Adult Mice.Wenwen Liu, Yunhui Guan, Sicong Qiao
|Feb 05, 2021
Discovery of Novel Plasmodium falciparum HDAC1 Inhibitors with Dual-Stage Antimalarial Potency and Improved Safety Based on the Clinical Anticancer Drug Candidate Quisinostat.Ruoxi Li, Dazheng Ling, Tongke Tang
|Aug 16, 2018
Rational Design of Novel Selective Dual-Target Inhibitors of Acetylcholinesterase and Monoamine Oxidase B as Potential Anti-Alzheimer's Disease Agents.Yixiang Xu, Jian Zhang, Huan Wang
|Jan 30, 2018
Discovery of Potent Benzocycloalkane Derived Diapophytoene Desaturase Inhibitors with an Enhanced Safety Profile for the Treatment of MRSA, VISA, and LRSA Infections.Baoli Li, Shuaishuai Ni, Feifei Chen
|Dec 16, 2017
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity.Baoli Li, Shuaishuai Ni, Fei Mao
Pageof 2
